Beta-blockers for heart failure. Experiences and recommendations for clinical use;Betabloccanti nello scompenso cardiaco. Esperienze e suggerimenti per l'impiego clinico

Giornale Italiano di Cardiologia

Volumn 28, Issue 1, 1998, Pages 61-70

  Sinagra, Gianfranco ^a   Boccanelli, Alessandro ^a   Camerini, Fulvio ^a   Gavazzi, Antonello ^a   Gronda, Edoardo ^a   Maggioni, Aldo P ^a   Opasich, Cristina ^a   Rapezzi, Claudio ^a   Scherillo, Marino ^a   Tavazzi, Luigi ^a  

^a ANMCO RESEARCH CENTER   (Italy)

Author keywords

Beta blockers; Cardiac failure

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; METOPROLOL;

CLINICAL PRACTICE; DRUG USE; HEART FAILURE; HUMAN; PRACTICE GUIDELINE; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; AGED; BISOPROLOL; CARBAZOLES; CONTROLLED CLINICAL TRIALS; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; METOPROLOL; PROPANOLAMINES; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; TIME FACTORS; VASODILATOR AGENTS;

EID: 13144282709     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. MC KEE PA, CASTELLI WP, MC NAMARA PM, KANNEL WB The natural history of congestive heart failure the Framingham Study N Engl J Med 1971, 285 1441-1446
2. THE CONSENSUS TRIAL GROUP Effects of enalapril on mortality in severe congestive heart failure N Engl J Med 1987, 316 1429-1435
3. THE SOLVD INVESTIGATORS Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure N Engl J Med 1991, 325 293-302
4. PACKER MD The neurohormonal hypothesis a theory to explain the mechanism of disease progression in heart failure J Am Coll Cardiol 1992, 20 248-254
5. EICHHORN EJ, BRISTOW MR Medical therapy can improve the biological properties of the chronically failing heart Circulation 1996, 94 2285-2296
6. HEILBRUNN SM, SHAH P, BRISTOW MR, VALANTINE HA, GINSBURG R, FOWLER MB Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy Circulation 1989, 79 483-490
7. WAAGSTEIN F, CAIDAHL K, WALLENTIN I, BERGH C, HJALMARSON A Long term beta-blockade in dilated cardiomyopathy effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol Circulation 1989, 80 551-563
8. OLSSON G, REHNQUIST N, SJOGREN A, ERHARDT L, LUNDMAN T Long term treatment with metoprolol after myocardial infarction effect on 3 year mortality and morbidity J Am Coll Cardiol 1985, 5 1428-1437
9. LICHSTEIN E, HAGER D, GREGORY JJ, FLEISS JL, ROLNITZKY LM, BIGGER JT JR, FOR THE MULTICENTER DILTIAZEM POST-INFARCTION RESEARCH GROUP Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure J Am Coll Cardiol 1990, 16 1327-1332
10. CHADDA K, GOLDSTEIN S, BYINGTON R, CURB D Effect of propranolol after acute myocardial infarction in patients with congestive heart failure Circulation 1986, 73 503-510
11. PEDERSEN TR FOR THE NORWEGIAN MULTICENTER STUDY GROUP Six-year follow-up of the Norwegian Multicenter Study on Timolol after acute myocardial infarction N Engl J Med 1985, 313 1055-1058
12. WAAGSTEIN F, HJALMARSON A, VARNAUSKAS E, WALLENTIN I Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy Br Heart J 1975, 37 1022-1036
13. EICHHORN EJ, HEESCH CM, BARNETT JH, ET AL Effect of metoprolol on myocardial function and energetics in patients with non ischemic dilated cardiomyopathy a randomized, double-blind, placebo-controlled study J Am Coll Cardiol 1994, 24 1310-1320
14. ENGELMEIER RS, O'CONNELL JB, WALSH R, RAD N, SCANLON PJ GUNNAR RM Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy a double-blind, randomized, placebo-controlled trial Circulation 1985, 72 536-546
15. ANDERSON JL, LUTZ JR, GILBERT EM, ET AL A randomized trial of low dose of beta-blockade therapy for idiopathic dilated cardiomyopathy Am J Cardiol 1985, 55 471-475
16. WAAGSTEIN F, BRISTOW MR, SWEDBERG K, ET AL Beneficial effects of metoprolol in dilated cardiomyopathy Lancet' 1993, 342 1441-1446
17. FISHER ML, GOTTLIEB SS, PLOTNICK GD, ET AL Beneficial effects of metoprolol in heart failure associated with coronary artery disease a randomized trial J Am Coll Cardiol 1994, 23 943-950
18. CIBIS INVESTIGATORS AND COMMITTEES A randomized trial of betablockade in heart failure the Cardiac Insufficiency Bisoprolol Study (CIBIS) Circulation 1994, 90 1765-1773
19. METRA M, NARDI M, GIUBBINI R, ET AL Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy J Am Coll Cardiol 1994, 24 1678-1687
20. OLSEN SL, GILBERT EM, RENLUND DG, ET AL Carvedilol improves left ventricular function and symptoms in chronic heart failure a double-blind randomized study J Am Coll Cardiol 1995, 25 1225-1231
21. KRUM H, SACKNER-BERNSTEIN JD, GOLDSMITH RL, ET AL Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure Circulation 1995, 92 1499-1506
22. AUSTRALIA/NEW ZEALAND HEART FAILURE RESEARCH COLLABORATIVE GROUP Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease Lancet 1997, 349 375-380
23. PACKER M, BRISTOW MR, COHN JN, ET AL The effects of carvedilol on morbidity and mortality in patients with chronic heart failure N Engl J Med 1996, 334 1349-1355
24. IKRAM H, FITZPATRICK D Double-blind trial of chronic oral beta-blockade in congestive cardiomyopathy Lancet 1981, II 490-492
25. CURRIE PJ, KELLY MY, MCKENZIE A, ET AL Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy J Am Coll Cardiol 1984, 3 203-209
26. SWEDBERG K, HJALMARSON A, WAAGSTEIN F, WALLANTIN I Beneficial effects of long term beta-blockade in congestive cardiomyopathy Br Heart J 1980, 44 117-133
27. HALL SA, CIGARROA CG, MARCOUX L, RISSER RC, GRAYBURN PA, EICHHORN EJ Time course of improvement in left ventricuilar function, mass and geometry in patients with congestive heart failure treated with beta adrenergic blockade J Am Coll Cardiol 1995, 25 1154-1161
28. DOUGHTY RN, WHALLEY GA, GAMBLE G, MACMAHON S, SHARPE N Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease J Am Coll Cardiol 1997, 29: 1060-1066.
29. WOODLEY SL, GILBERT EM, ANDERSON L, ET AL Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy Circulation 1991, 84 2426-2441
30. YUE TL, CHENG HY, LYSKO PG, ET AL Carvedilol, a new vasodilator and beta-adrenoceptor antagonist, is antioxidant and free radical scavenger J Pharmacol Exp Ther 1992, 263 92-98
31. RUFFOLO RR, GELAI M, HIEBLE JP, WILLETTE RN, NICHOLS AJ The pharmacology of carvedilol Eur J Clin Pharmacol 1990, 38 (Suppl 2) 502-508
32. BRISTOW MR, LARRABEE P, MINOBE W, ET AL. Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes J Clin Invest 1992, 70 S105-S113
33. BRISTOW MR, GILBERT EM, ABRAHAM WT, ET AL Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure Circulation 1996, 94 2807-2816
34. COLUCCI WS, PACKER M, BRISTOW MR, ET AL Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure Circulation 1996, 94 2800-2806
35. PACKER M, COLUCCI WS, SACKNER-BERNSTEIN J, ET AL Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure The PRECISE Trial Circulation 1996, 94 2793-2799
36. GILBERT EM, ABRAHAM WT, OLSEN S, ET AL Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart Circulation 1996, 94 2817-2825
37. DI LENARDA A, GREGORI D, LARDIERI G, ET AL Metoprolol in dilated cardiomyopathy is it possible to identify factors predictive of improvement? J Cardiac Failure 1996, 2 87-102
38. YAMADA Y, FUKUNAMI M, OHMURI M, ET AL Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologic viewpoint J Am Coll Cardiol 1992, 21 628-633
39. SINAGRA G, RAKAR S, ZECCHIN M, ET AL: Non predictive value of fibrosis in dilated cardiomyopathy treated with metoprolol J Cardiovasc Pathol 1996, 5 21-28.
40. SCHWARTZ BM, SACKNER-BERNSTEIN J, PENN J, ET AL Which patients with chronic heart failure are most likely to show hemodynamic and functional improvement following long-term betablockade? (abstract) J Am Coll Cardiol 1992, 19 341A
41. EICHHORN EJ, HEESCH CM, RISSER RC, ET AL Predictors of systolic and diastolic improvement in patients with dilated cardiomyopathy treated with metoprolol J Am Coll Cardiol 1995, 25 154-162
42. CLELAND JGF, BRISTOW MR, ERDMANN E, REMME WJ, SWEDBERG K, WAAGSTEIN F Beta blocking agents in heart failure Should they used and how? Eur Heart J 1996, 17 1629-1639